-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Rapid Therapeutic Science Laboratories, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2017 to Q2 2023.
- Rapid Therapeutic Science Laboratories, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2023 was $150K, a 64% increase year-over-year.
- Rapid Therapeutic Science Laboratories, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was $607K.
- Rapid Therapeutic Science Laboratories, Inc. annual Nonoperating Income (Expense) for 2022 was -$531K, a 23.2% increase from 2021.
- Rapid Therapeutic Science Laboratories, Inc. annual Nonoperating Income (Expense) for 2021 was -$692K, a 1093% decline from 2020.
- Rapid Therapeutic Science Laboratories, Inc. annual Nonoperating Income (Expense) for 2020 was -$58K, a 69.7% increase from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)